Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline and Vitamin B3 for Ataxia Telangiectasia (Before-After Study)
IRCT20250624066242N5Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of minocycline and niacin in ataxia-telangiectasia (AT), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Motor function improvement and Quality of life improvement. Started Jun 2026; status: completed.
02
Drugs
minocyclineniacin
03
Conditions
ataxia-telangiectasia (AT)
Beyond the preview
Go deeper on IRCT20250624066242N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250624066242N5.